Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Mod Pathol. 2014 Apr 25;27(12):1578–1589. doi: 10.1038/modpathol.2014.66

Table 1.

Lymph node status associated with pathologic features.

All Cases
N
Node negative
N (%)
Node positive
N (%)
p-value
Tumor Stage
 T1a (intramucosal) 72 69 (96) 3 (4) <0.001
 T1b (submucosal) 138 100 (72) 38 (28)
Depth of Invasion, Intramucosal Only
 T1a superficial 35 34 (97) 1 (3) 1.000
 T1a deep 37 35 (95) 2 (5)
Depth of Invasion, Submucosal Only
 T1b superficial 72 57 (79) 15 (21) 0.049
 T1b deep 66 43 (65) 23 (35)
Lymph Node Stage
 N0 (0 positive lymph nodes) 169 169 (100) 0 (0) N/A
 N1 (1–2 positive lymph nodes) 26 0 (0) 26 (100)
 N2 (3–6 positive lymph nodes) 10 0 (0) 10 (100)
 N3 (>6 positive lymph nodes) 5 0 (0) 5 (100)
Lymph nodes examined (median, interquartile range) 20 (13–28) 19 (14–28) 20 (13–28) 0.969
WHO Tumor Grade
 Well differentiated 40 38 (95) 2 (5) 0.003
 Moderately differentiated 138 111 (80) 27 (20)
 Poorly differentiated 32 20 (62) 12 (38)
Tumor Budding
 None 117 105 (90) 12 (10) <0.001
 Focal (1 to 2 budding fields) 34 29 (85) 5 (15)
 Extensive (≥ 3 budding fields) 59 35 (59) 24 (41)
Tumor Budding
 None or Focal (< 3 budding fields) 151 134 (89) 17 (11) <0.001
 Extensive (≥ 3 budding fields) 59 35 (59) 26 (41)
Angiolymphatic Invasion
Absent 174 150 (86) 24 (14) <0.001
Present 36 19 (53) 17 (47)
Tumor Size
 < 2 cm 105 97 (92) 8 (8) <0.001
 ≥ 2 cm 105 72 (69) 33 (31)